Phil - Headquarter Locations, Products, Competitors ... - CB Insights

• Overview & Products
• Financials
• People
• Alternatives & Competitors

Founded Year

2015

Stage

Debt | Alive

Total Raised

$186.1M

Last Raised

$60M | 7 mos ago

Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+12 points in the past 30 days

About Phil

Phil provides technology solutions in the pharmaceutical sector, focusing on patient access and adherence. The company offers a digital hub and direct-to-patient solutions that assist in the medication access process for patients and healthcare providers. Phil serves pharmaceutical manufacturers, patients, and healthcare providers by offering integrated technology solutions facilitating medication access. It was founded in 2015 and is based in Scottsdale, Arizona.

Headquarters Location

14500 North Northsight Boulevard Suite 307

Scottsdale, Arizona, 85260,

United States

855-977-0975

Loading...

ESPs containing Phil

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGERPrescription delivery & distribution servicesEnterprise Tech / Supply Chain & Procurement

The prescription delivery & distribution services market provides solutions that deliver prescription medications from pharmacies to patients' homes or other designated locations. These services help to ensure timely access to medications, in turn improving medication adherence and enhancing the overall patient experience, particularly for individuals with chronic conditions, mobility limitations,…

Phil named as Challenger among 15 other companies, including Walmart, Amazon, and Instacart.

View all ESPs

Loading...

Research containing Phil

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Phil in 1 CB Insights research brief, most recently on Apr 8, 2024.

Apr 8, 2024

The digital pharmacy tech market mapView all research

Expert Collections containing Phil

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Phil is included in 4 Expert Collections, including E-Commerce.

EE-Commerce

11,526 items

Companies that sell goods online (B2C), or enable the selling of goods online via tech solutions (B2B).

DDigital Health

12,406 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

TTelehealth

3,127 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

HHLTH 2025 Exhibitors

878 items

A look at the HLTH Vegas 2025 exhibitor list we’ve been building so your team can start scanning for relevant companies.

Learn more by requesting a demo

Phil Patents

Phil has filed 45 patents.

The 3 most popular patent topics include:

• graphical projections
• technical drawing
• roadsters

View Patents Chart

Application Date	Grant Date	Title	Related Topics	Status
3/25/2024	12/30/2025	Roof support structure and support straps	Grant

Application Date	3/25/2024
Grant Date	12/30/2025
Title	Roof support structure and support straps
Related Topics
Status	Grant

Learn more by requesting a demo

Latest Phil News

PHIL and Sprout Pharmaceuticals Expand Their Affordable Direct-to-Patient Access Program for Addyi(flibanserin)

Jan 14, 2026

PHIL and Sprout Pharmaceuticals Expand Their Affordable Direct-to-Patient Access Program for Addyi(flibanserin) PHIL expands direct-to-patient access to Addyi for as low as $40 per year with commercial insurance coverage or $149 per month cash whether accessed through telehealth or a doctor's office. SCOTTSDALE, Ariz., Jan. 8, 2026 /PRNewswire/ -- PHIL, the technology-powered patient access platform designed to help patients get easy and affordable access to their prescribed medications, and Sprout Pharmaceuticals, today announced that they have expanded Sprout's direct-to-patient program for Addyi (flibanserin). Addyi has recently received an expanded indication from the FDA and is now approved to treat hypoactive sexual desire disorder (HSDD) in women less than 65 years of age. Addyi , an HSDD therapy developed by Sprout Pharmaceuticals, is made for women experiencing distressing low desire and is the only FDA-approved pill proven to increase a woman's sex drive in both premenopausal and postmenopausal women. The goal of the expanded direct-to-patient program is to help patients prescribed Addyi have a more accessible, convenient, and affordable path to start and remain on therapy. Addyi's robust direct-to-patient solution powered by PHIL, offers seamless medication access with telemedicine services, the lowest out-of-pocket cost for commercially insured and cash-pay patients, and free home delivery across the U.S. Through PHILRx, Addyi may cost as low as $40 per year with commercial insurance coverage or $149 per month for cash pay. All patients receive free home delivery. Healthcare providers can send prescriptions to PHILRx through their EMR. For more information, see  phil.us/addyi . "The best patient experience begins with affordable access. We're incredibly proud of our partnership with PHIL because it ensures that women prescribed Addyi, whether through an in-office visit or telehealth, can obtain the medication at the right price. Today 80% of Addyi patients pay under $100 per month through PHILRx, with more than half paying $40 annually with insurance coverage. This program delivers on exactly what we set out to do, it removes longstanding barriers to access in women's sexual health," said Cindy Eckert, CEO of Sprout Pharmaceuticals. Whether prescriptions come from an in-office doctor or a telehealth provider, PHIL helps make the prescription experience simple, convenient, and affordable. Patients prescribed Addyi can receive their prescription on time and at their doorstep — with affordability support designed to help patients pay the lowest out-of-pocket cost available. Additionally, PHIL offers proactive refill support to help patients stay adherent to therapy. "Patients deserve a medication access experience that's as modern as the science," said Deepak Thomas, Founder & CEO of PHIL. "When a clinician decides Addyi is appropriate, PHIL helps remove barriers commonly found in traditional access challenges, with an affordability-first approach that's built around the patient." About PHIL/PHILRx PHIL is on a mission to improve patients' lives through innovative technology and dedicated support. The PHIL platform is designed to help more patients start and stay on therapy, quickly, easily and affordably. Learn more at  www.phil.us . About Sprout Pharmaceuticals Sprout Pharmaceuticals is leading a revolution in women's health, pioneering innovative treatments that address long-overlooked needs. With the launch of Addyi, the first and only FDA-approved pill to treat low sexual desire (HSDD), Sprout helped shift the conversation around women's sexual wellness. The company remains committed to advancing science, expanding access, and advocating for the care women deserve. See full prescribing Information, including Boxed Warning regarding severe low blood pressure and fainting in certain settings at  addyi.com/pi Media Contact:

Jan 8, 202609:00 ET PHIL and Sprout Pharmaceuticals Expand Their Affordable Direct-to-Patient Access Program for Addyi(flibanse...Sep 23, 2025PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in PharmaSep 22, 2025PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in PharmaSep 22, 2025PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in PharmaLearn more by requesting a demo

Phil Frequently Asked Questions (FAQ)

• When was Phil founded?

  Phil was founded in 2015.

• Where is Phil's headquarters?

  Phil's headquarters is located at 14500 North Northsight Boulevard, Scottsdale.

• What is Phil's latest funding round?

  Phil's latest funding round is Debt.

• How much did Phil raise?

  Phil raised a total of $186.1M.

• Who are the investors of Phil?

  Investors of Phil include K2 HealthVentures, Warburg Pincus, Uncork Capital, Crosslink Capital, Tarsadia Investments and 17 more.

• Who are Phil's competitors?

  Competitors of Phil include Alto Pharmacy, Blink Health, Truepill, Medly, Arrive Health and 7 more.

Loading...

Compare Phil to Competitors

Capsule

Capsule is a pharmacy technology company that offers prescription delivery services. The company provides same-day prescription delivery and facilitates communication with pharmacists via text or chat. Capsule primarily serves individuals who require medication management. It was founded in 2015 and is based in New York, New York.

Blink Health

Blink Health operates in the healthcare sector. It operates with a focus on providing a digital concierge service for patients prescribed branded medications. The company offers a pharma-to-patient cloud platform that provides pricing information and home delivery options to facilitate access to medications. BlinkRx primarily serves the healthcare industry. It was founded in 2014 and is based in New York, New York.

Nimble

Nimble provides pharmacy and prescription management solutions within the healthcare sector. The company offers services that focus on digital ordering and operational processes, as well as marketing strategies aimed at patient retention and adherence to prescriptions. Nimble serves pharmacies, patients, and manufacturers in the healthcare industry. Nimble was formerly known as Nimble Pharmacy. It was founded in 2015 and is based in Redwood City, California.

Arrive Health

Arrive Health serves as a healthcare technology company that focuses on improving care decisions for patients and providers. The company offers solutions that provide accurate clinical, cost, and coverage data within electronic health record (EHR) systems and other healthcare workflows to support informed decision-making. Arrive Health primarily serves sectors such as health systems, providers, health plans, pharmacy benefit managers (PBMs), and technology vendors in the healthcare industry. Arrive Health was formerly known as RxRevu. It was founded in 2013 and is based in Denver, Colorado.

ScriptDrop

ScriptDrop focuses on medication access and prescription delivery within the healthcare sector. The company offers a platform for pharmacies, providers, and patients to facilitate medication delivery. ScriptDrop primarily serves pharmacies and healthcare providers. It was founded in 2016 and is based in Columbus, Ohio.

PPopulus Health Technologies

Populus Health Technologies focuses on virtual care patient acquisition within the healthcare and pharmaceutical sectors. The company provides a platform that integrates brand and clinical messaging into virtual care consultations. Populus Health Technologies serves the healthcare industry, concentrating on virtual care media and provider engagement. Populus Health Technologies was formerly known as Populus Media. It was founded in 2019 and is based in Princeton, New Jersey.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.

I ACCEPTI DO NOT ACCEPT